AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2014
Jan 2, 2014
34105_dirs_2014-01-02_9e582a17-759b-48db-8687-d8e76245a759.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2014-01-01
Reporting Person: POPIELEC MICHAEL D (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-01 | Common Stock; $.10 par value | M | 18780 | — | Acquired | 203780 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-01 | Restricted Stock Units | $0 | J | 11220 | Disposed | 2020-12-30 | Common Stock (30000) | Direct |
Footnotes
F1: Represents the conversion of 30,000 restricted stock units previously awarded to Michael D. Popielec on June 4, 2013 upon the vesting of such restricted stock units on January 1, 2014. The Company retained 11,220 of the 30,000 shares of common stock issuable to Michael D. Popielec in satisfaction of his individual minimum statutory tax withholding obligation at a price per share determined as of the vesting date.
More from ULTRALIFE CORP
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 16